Search PubMed⌕ Search

Biomedical subjects

B Poitevin

Publications and source records attributed to B Poitevin.

At least 19 recordsLinked to original sources
PubMed1999

Integrating homoeopathy in health systems.

Homoeopathy is a therapy which involves many components and three main agents: the patient, with his or her condition and personal characteristics; the medication used, with its composition and manufacturing procedure; and the physician, with his or her approach to treatment and concepts of health. The development of research and evaluation structures, combined with a critical education in the discipline, would help to improve practices and define homoeopathy's potential role in relation to the other therapies, both conventional and unconventional, used in Western health systems.

Brazil↗
PubMed1996

Optokinetic and vestibulo-ocular reflex adjustment by GABA antagonists.

We determined if high and low doses of anti-GABAergic drugs have opposite effects on the visuo-vestibular activity in pigmented rats and examined a possible correlation with the level of GABA in the related structures. First, the horizontal optokinetic and vestibulo-ocular reflexes of most animals were depressed by high doses of anti-GABAergic drugs (10(-3) M purified picrotoxin or 10(-6) M picrotoxin in unpurified vegetal extract). Simultaneously, a drop in GABA level in the cerebellum and posterior brainstem was detected. Second, after a subsequent injection (1 ml) of the diluted extract (10(-13) M picrotoxin), the reflexes returned to normal despite the fact that no correlation with the GABA level was found. These results demonstrate that small doses of anti-GABAergic drugs reverse the depressive effect created by large doses of these drugs on the oculomotor system, and even adjust the reflexes to the stimulation. This adjustment, without correlation with the GABA level, suggest a powerful effect of very low dose of the drug to modulate either the activity of the cerebellar inhibiting input or of the vestibular nuclei neurons or to trigger the adaptation by other neurotransmitter systems involved in the performances of the reflexes.

Animals↗
PubMed1989

[The effect of dilutions of Apis mellifica and Apium virus on ultraviolet light-induced erythema in the guinea pig].

Dilutions of Apis mellifica (obtained from the whole bee) and Apium virus (obtained from bee venom) are used classically in homeopathy for inflammatory symptoms with edema, erythema and pruritus (Lewis triad). Using a method examining the evolution of UV induced erythema in the guinea pig, the authors show the following dilutions of Apis mellifica 7 CH(10(-14)), 9 CH(10(-18)) and of Apium virus 5 CH(10(-10)), 7 CH(10(-14)), 9 CH(10(-18)) exert an action on experimental erythema. The results are statistically significant for the dilutions at the 48th hour after irradiation.

Animals↗
PubMed1988

In vitro immunological degranulation of human basophils is modulated by lung histamine and Apis mellifica.

1. The effect of high dilutions of two homeopathic drugs Lung histamine (Lung his) and Apis mellifica (Apis mel) used for the treatment of allergic diseases has been assessed on in vitro human basophil degranulation. Experiments were conducted blind. 2. Basophil degranulation induced by 1.66 X 10(-9) M anti-IgE antibody was significantly inhibited in the presence of 5 Lung his (5th centesimal dilution of Lung his) and 15 Lung his (15th centesimal dilution of Lung his) by 28.8% and 28.6% respectively and by 65.8% in the presence of 9 Apis mel (9th centesimal dilution of Apis mel). Basophil degranulation induced by 1.66 X 10(-16) to 1.66 X 10(-18) M anti-IgE antibody was also inhibited by high dilutions of Lung his and Apis mel with an inhibition of nearly 100% with 18 Lung his (18th centesimal dilution of Lung his) and 10 Apis mel (10th centesimal dilution of Apis mel). An alternance of inhibition, inactivity and stimulation was observed when basophils were incubated in the presence of serial dilutions of Lung his and Apis mel. 3. The investigation of the clinical efficacy of high dilutions of Lung his and Apis mel should be envisaged in allergic diseases in parallel with in vitro and ex vivo biological assays.

Animals↗
PubMed1987

Effect of mouse peritoneal macrophages of orally administered very high dilutions of silica.

The activity of very high dilutions of silica, a substance cytotoxic for macrophages, was tested on the synthesis by mouse peritoneal macrophages of the inflammatory ether-lipid paf-acether and its precursor lyso paf-acether. C57Bl6 female mice received for 25 days either 1.66 X 10(-11) M silica (11 sil) or 1.66 X 10(-19) M (19 sil) (final concentration) in the tap-water they were given to drink while control mice remained untreated. Isolated macrophages from mice treated with 11 sil produced 44.2 and 30.8% more paf-acether than cells from untreated mice in the presence of 50 and 200 micrograms zymosan (Z)/ml respectively. When 19 sil was given to the mice, the respective increases were 67.5 and 38%. In an experiment with a blind design, the mice were either untreated or received 19 sil or saline submitted to the same dilution procedure (19 sal). After administration of 19 sil, paf-acether synthesis was 55.5 and 33.5% higher upon stimulation with 50 and 200 micrograms Z/ml, respectively, than in the 19 sal group. In a third blind experiment, macrophages from mice that received 19 sil formed 61.3 and 28.6% more paf-acether upon stimulation with 50 and 200 micrograms Z/ml respectively, as compared to mice receiving 19 sal or lactose submitted to the same dilution procedure (19 lac). There was no difference between the 19 sal and the 19 lac groups. The differences between control and silica-treated mice were highly statistically significant in all experiments. There was no effect on the synthesis of lyso paf-acether. These results demonstrate clear ex vivo cellular effect of high dilutions of silica, that cannot be explained in our present state of knowledge.

Administration, Oral↗
PubMed1984

Paf-acether generates chemiluminescence in human neutrophils in the absence of cytochalasin B.

In the absence of cytochalasin B, synthetic Paf-acether (0.1-10 microM) induced oxygen radical production in polymorphonuclear neutrophils as measured by the luminol-dependent chemiluminescence ( LDCL ) test. This effect was observed after a lag period of 10 s and was maximal between 5 and 15 min. In the presence of cytochalasin B, the kinetics were shortened, but the lag period was not modified and the same concentrations of the agonist had to be used to induce LDCL . None of the structural analogs tested (2-lyso Paf-acether, Paf-acether enantiomer, 1 ester analog of Paf-acether, lyso-phosphatidylcholine) were active, irrespective of the presence of cytochalasin B. Paf-acether (10 microM) shortened the kinetics of opsonized zymosan (10 micrograms/ml)-induced LDCL and enhanced it by 550% and 250% at 5 min and 10 min respectively, without affecting the peak value. Similar results were obtained using non-opsonized zymosan (100 micrograms/ml). Lower concentrations of Paf-acether (0.1 microM) were also able to increase oxygen radical production induced by low doses of zymosan and opsonized zymosan. The triggering and enhancing effects of Paf-acether on oxygen radical production by resting and stimulated polymorphonuclear neutrophils support the role of Paf-acether in inflammation.

Cytochalasin B↗
PubMed1982

Platelet-activating factor (PAF-acether), an activator of neutrophil functions.

The effect of totally synthetic PAF-acether (1-O-octadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine), 2-lyso PAF-acether (1-O-octadecyl-sn-glyceryl-3-phosphorylcholine) and lyso-phosphatidylcholine on enzyme release and superoxide production from human polymorphonuclear neutrophils (PMN were studied. PMN (2 X 10(6) ml-1) were incubated at 37 degrees C with various concentrations of phospholipids in the absence of cytochalasin B. At 10(-7) M, PAF-acether induced superoxide production and beta-glucuronidase, acid phosphatase and lysosyme release, but not that of cytoplasmic lactic dehydrogenase. In the same condition 2-lyso PAF-acether and lyso-phosphatidylcholine were ineffective. In the presence of phagocytic stimuli PAF-acether enhanced in the range from 10(-7) M to 10(-10) M the enzyme release and only at 10(-7) M the superoxide production. Thus, the capacity of PAF-acether to stimulate PMN, as well as platelet function, indicates a prominent role for this lipid mediator in inflammatory processes.

Humans↗